Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 71 of 71 entries
Sorted by: Best Match Show Resources per page
[Mortality in lung cancer and COPD].

Archivos de bronconeumologia

Soriano JB.
PMID: 20096983
Arch Bronconeumol. 2010 May;46(5):281-2; author reply 282. doi: 10.1016/j.arbres.2009.11.010. Epub 2010 Jan 22.

No abstract available.

Cite
Soriano JB. Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica. [Mortality in lung cancer and COPD]. Arch Bronconeumol. 2010;46(5):281-2; author reply 282doi: 10.1016/j.arbres.2009.11.010.
Soriano, J. B. (2010). Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica. [Mortality in lung cancer and COPD]. Archivos de bronconeumologia, 46(5), 281-2; author reply 282. https://doi.org/10.1016/j.arbres.2009.11.010
Soriano, Joan B. "Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica." [Mortality in lung cancer and COPD]. Archivos de bronconeumologia vol. 46,5 (2010): 281-2; author reply 282. doi: https://doi.org/10.1016/j.arbres.2009.11.010
Soriano JB. Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica. [Mortality in lung cancer and COPD]. Arch Bronconeumol. 2010 May;46(5):281-2; author reply 282. doi: 10.1016/j.arbres.2009.11.010. Epub 2010 Jan 22. Spanish. PMID: 20096983.
Copy Download .nbib Format: NLM
Stat bite: Most common causes of cancer death in the United kingdom, 2002.

Journal of the National Cancer Institute

[No authors listed]
PMID: 15840876
J Natl Cancer Inst. 2005 Apr 20;97(8):558. doi: 10.1093/jnci/97.8.558.

No abstract available.

Cite
Stat bite: Most common causes of cancer death in the United kingdom, 2002. J Natl Cancer Inst. 2005;97(8):558doi: 10.1093/jnci/97.8.558.
(2005). Stat bite: Most common causes of cancer death in the United kingdom, 2002. Journal of the National Cancer Institute, 97(8), 558. https://doi.org/10.1093/jnci/97.8.558
"Stat bite: Most common causes of cancer death in the United kingdom, 2002." Journal of the National Cancer Institute vol. 97,8 (2005): 558. doi: https://doi.org/10.1093/jnci/97.8.558
Stat bite: Most common causes of cancer death in the United kingdom, 2002. J Natl Cancer Inst. 2005 Apr 20;97(8):558. doi: 10.1093/jnci/97.8.558. PMID: 15840876.
Copy Download .nbib Format: NLM
Pushing the envelope of disparity research to find modifiable factors.

JAMA surgery

Chang DC.
PMID: 23324840
JAMA Surg. 2013 Jan;148(1):42-3. doi: 10.1001/jamasurgery.2013.405.

No abstract available.

Cite
Chang DC. Pushing the envelope of disparity research to find modifiable factors. JAMA Surg. 2013;148(1):42-3doi: 10.1001/jamasurgery.2013.405.
Chang, D. C. (2013). Pushing the envelope of disparity research to find modifiable factors. JAMA surgery, 148(1), 42-3. https://doi.org/10.1001/jamasurgery.2013.405
Chang, David C. "Pushing the envelope of disparity research to find modifiable factors." JAMA surgery vol. 148,1 (2013): 42-3. doi: https://doi.org/10.1001/jamasurgery.2013.405
Chang DC. Pushing the envelope of disparity research to find modifiable factors. JAMA Surg. 2013 Jan;148(1):42-3. doi: 10.1001/jamasurgery.2013.405. PMID: 23324840.
Copy Download .nbib Format: NLM
Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Riaz SP, Horton M, Kang J, Mak V, Lüchtenborg M, Møller H.
PMID: 21892107
J Thorac Oncol. 2011 Dec;6(12):2005-10. doi: 10.1097/JTO.0b013e31822b02db.

INTRODUCTION: Most previous studies have investigated either socioeconomic deprivation or urbanization in relationship to lung cancer incidence or survival. We investigated the association between socioeconomic deprivation, urbanization, and lung cancer incidence and survival in England.METHODS: We extracted data on...

Cite
Riaz SP, Horton M, Kang J, et al. Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol. 2011;6(12):2005-10doi: 10.1097/JTO.0b013e31822b02db.
Riaz, S. P., Horton, M., Kang, J., Mak, V., Lüchtenborg, M., & Møller, H. (2011). Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 6(12), 2005-10. https://doi.org/10.1097/JTO.0b013e31822b02db
Riaz, Sharma P, et al. "Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 6,12 (2011): 2005-10. doi: https://doi.org/10.1097/JTO.0b013e31822b02db
Riaz SP, Horton M, Kang J, Mak V, Lüchtenborg M, Møller H. Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol. 2011 Dec;6(12):2005-10. doi: 10.1097/JTO.0b013e31822b02db. PMID: 21892107.
Copy Download .nbib Format: NLM
Is 20% of a loaf enough?.

Cancer

Carreras G, Gorini G, Paci E.
PMID: 23775509
Cancer. 2013 Sep 15;119(18):3420. doi: 10.1002/cncr.28167. Epub 2013 Jun 17.

No abstract available.

Cite
Carreras G, Gorini G, Paci E. Is 20% of a loaf enough?. Cancer. 2013;119(18):3420doi: 10.1002/cncr.28167.
Carreras, G., Gorini, G., & Paci, E. (2013). Is 20% of a loaf enough?. Cancer, 119(18), 3420. https://doi.org/10.1002/cncr.28167
Carreras, Giulia, et al. "Is 20% of a loaf enough?." Cancer vol. 119,18 (2013): 3420. doi: https://doi.org/10.1002/cncr.28167
Carreras G, Gorini G, Paci E. Is 20% of a loaf enough?. Cancer. 2013 Sep 15;119(18):3420. doi: 10.1002/cncr.28167. Epub 2013 Jun 17. PMID: 23775509.
Copy Download .nbib Format: NLM
Risk classification of cancer survival using ANN with gene expression data from multiple laboratories.

Computers in biology and medicine

Chen YC, Ke WC, Chiu HW.
PMID: 24631783
Comput Biol Med. 2014 May;48:1-7. doi: 10.1016/j.compbiomed.2014.02.006. Epub 2014 Feb 22.

Numerous cancer studies have combined gene expression experiments and clinical survival data to predict the prognosis of patients of specific gene types. However, most results of these studies were data dependent and were not suitable for other data sets....

Cite
Chen YC, Ke WC, Chiu HW. Risk classification of cancer survival using ANN with gene expression data from multiple laboratories. Comput Biol Med. 2014;48:1-7doi: 10.1016/j.compbiomed.2014.02.006.
Chen, Y. C., Ke, W. C., & Chiu, H. W. (2014). Risk classification of cancer survival using ANN with gene expression data from multiple laboratories. Computers in biology and medicine, 481-7. https://doi.org/10.1016/j.compbiomed.2014.02.006
Chen, Yen-Chen, et al. "Risk classification of cancer survival using ANN with gene expression data from multiple laboratories." Computers in biology and medicine vol. 48 (2014): 1-7. doi: https://doi.org/10.1016/j.compbiomed.2014.02.006
Chen YC, Ke WC, Chiu HW. Risk classification of cancer survival using ANN with gene expression data from multiple laboratories. Comput Biol Med. 2014 May;48:1-7. doi: 10.1016/j.compbiomed.2014.02.006. Epub 2014 Feb 22. PMID: 24631783.
Copy Download .nbib Format: NLM
A simple numerical discriminant in the follow-up of lung cancer.

Clinical radiology

Miller AL, Stokes TC, Stevens JF, Buckley-Sharp MD.
PMID: 6839647
Clin Radiol. 1983 May;34(3):251-3. doi: 10.1016/s0009-9260(83)80321-3.

Statistical analysis of laboratory data obtained during a study on a group of patients with lung cancer suggests that a simple numerical discriminant may have value in the follow-up of such patients. The discriminant is based on six common...

Cite
Miller AL, Stokes TC, Stevens JF, et al. A simple numerical discriminant in the follow-up of lung cancer. Clin Radiol. 1983;34(3):251-3doi: 10.1016/s0009-9260(83)80321-3.
Miller, A. L., Stokes, T. C., Stevens, J. F., & Buckley-Sharp, M. D. (1983). A simple numerical discriminant in the follow-up of lung cancer. Clinical radiology, 34(3), 251-3. https://doi.org/10.1016/s0009-9260(83)80321-3
Miller, A L, et al. "A simple numerical discriminant in the follow-up of lung cancer." Clinical radiology vol. 34,3 (1983): 251-3. doi: https://doi.org/10.1016/s0009-9260(83)80321-3
Miller AL, Stokes TC, Stevens JF, Buckley-Sharp MD. A simple numerical discriminant in the follow-up of lung cancer. Clin Radiol. 1983 May;34(3):251-3. doi: 10.1016/s0009-9260(83)80321-3. PMID: 6839647.
Copy Download .nbib Format: NLM
Lung cancer in China: current and prospect.

Current opinion in oncology

Wu F, Wang L, Zhou C.
PMID: 33165004
Curr Opin Oncol. 2021 Jan;33(1):40-46. doi: 10.1097/CCO.0000000000000703.

PURPOSE OF REVIEW: To describe the current status of lung cancer in China, including incidence, prevention, molecular testing and treatment.RECENT FINDINGS: Lung cancer presents a major public health issue and an enormous burden on society in China, because of...

Cite
Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021;33(1):40-46doi: 10.1097/CCO.0000000000000703.
Wu, F., Wang, L., & Zhou, C. (2021). Lung cancer in China: current and prospect. Current opinion in oncology, 33(1), 40-46. https://doi.org/10.1097/CCO.0000000000000703
Wu, Fengying, et al. "Lung cancer in China: current and prospect." Current opinion in oncology vol. 33,1 (2021): 40-46. doi: https://doi.org/10.1097/CCO.0000000000000703
Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021 Jan;33(1):40-46. doi: 10.1097/CCO.0000000000000703. PMID: 33165004.
Copy Download .nbib Format: NLM
Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC).

Journal of cancer research and clinical oncology

Ma X, Wang S, Zhang Y, Wei H, Yu J.
PMID: 32852633
J Cancer Res Clin Oncol. 2021 Feb;147(2):593-606. doi: 10.1007/s00432-020-03362-z. Epub 2020 Aug 27.

BACKGROUND: To evaluate the efficacy and safety of an immune checkpoint inhibitor (ICI) combined with chemotherapy in patients with advanced SCLC.METHODS: We searched published randomized-controlled trials (RCTs) to compare the effect of ICIs combined with chemotherapy and chemotherapy alone...

Cite
Ma X, Wang S, Zhang Y, et al. Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC). J Cancer Res Clin Oncol. 2020;147(2):593-606doi: 10.1007/s00432-020-03362-z.
Ma, X., Wang, S., Zhang, Y., Wei, H., & Yu, J. (2021). Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC). Journal of cancer research and clinical oncology, 147(2), 593-606. https://doi.org/10.1007/s00432-020-03362-z
Ma, Xiaoting, et al. "Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)." Journal of cancer research and clinical oncology vol. 147,2 (2021): 593-606. doi: https://doi.org/10.1007/s00432-020-03362-z
Ma X, Wang S, Zhang Y, Wei H, Yu J. Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC). J Cancer Res Clin Oncol. 2021 Feb;147(2):593-606. doi: 10.1007/s00432-020-03362-z. Epub 2020 Aug 27. PMID: 32852633.
Copy Download .nbib Format: NLM
Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis.

BMC pulmonary medicine

Huang KL, Wang SY, Lu WC, Chang YH, Su J, Lu YT.
PMID: 31296196
BMC Pulm Med. 2019 Jul 11;19(1):126. doi: 10.1186/s12890-019-0883-x.

BACKGROUND: The Nelson mortality results were presented in September 2018. Four other randomized control trials (RCTs) were also reported the latest mortality outcomes in 2018 and 2019. We therefore conducted a meta-analysis to update the evidence and investigate the...

Cite
Huang KL, Wang SY, Lu WC, et al. Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis. BMC Pulm Med. 2019;19(1):126doi: 10.1186/s12890-019-0883-x.
Huang, K. L., Wang, S. Y., Lu, W. C., Chang, Y. H., Su, J., & Lu, Y. T. (2019). Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis. BMC pulmonary medicine, 19(1), 126. https://doi.org/10.1186/s12890-019-0883-x
Huang, Kai-Lin, et al. "Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis." BMC pulmonary medicine vol. 19,1 (2019): 126. doi: https://doi.org/10.1186/s12890-019-0883-x
Huang KL, Wang SY, Lu WC, Chang YH, Su J, Lu YT. Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis. BMC Pulm Med. 2019 Jul 11;19(1):126. doi: 10.1186/s12890-019-0883-x. PMID: 31296196; PMCID: PMC6625016.
Copy Download .nbib Format: NLM
Lung cancer in patients living with HIV infection.

AIDS (London, England)

Meijide H, Mena A, Marcos PJ, Rodriguez-Osorio I, Suárez-Fuentetaja R, Castro A, Poveda E, Pedreira JD.
PMID: 26544707
AIDS. 2015 Nov;29(17):2363-4. doi: 10.1097/QAD.0000000000000840.

No abstract available.

Cite
Meijide H, Mena A, Marcos PJ, et al. Lung cancer in patients living with HIV infection. AIDS. 2015;29(17):2363-4doi: 10.1097/QAD.0000000000000840.
Meijide, H., Mena, A., Marcos, P. J., Rodriguez-Osorio, I., Suárez-Fuentetaja, R., Castro, A., Poveda, E., & Pedreira, J. D. (2015). Lung cancer in patients living with HIV infection. AIDS (London, England), 29(17), 2363-4. https://doi.org/10.1097/QAD.0000000000000840
Meijide, Hector, et al. "Lung cancer in patients living with HIV infection." AIDS (London, England) vol. 29,17 (2015): 2363-4. doi: https://doi.org/10.1097/QAD.0000000000000840
Meijide H, Mena A, Marcos PJ, Rodriguez-Osorio I, Suárez-Fuentetaja R, Castro A, Poveda E, Pedreira JD. Lung cancer in patients living with HIV infection. AIDS. 2015 Nov;29(17):2363-4. doi: 10.1097/QAD.0000000000000840. PMID: 26544707.
Copy Download .nbib Format: NLM
Showing 61 to 71 of 71 entries